Sex, Race, and Smoking Impact Olanzapine Exposure

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

2005 • 5,799 citations

Physicians Desk Reference

1994 • 2,653 citations

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

2006 • 1,125 citations

CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants

2002 • 747 citations

Estimation of population characteristics of pharmacokinetic parameters from routine clinical data

1977 • 681 citations

The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development

2003 • 634 citations

The Distribution of Human Genetic Diversity: A Comparison of Mitochondrial, Autosomal, and Y-Chromosome Data

2000 • 532 citations

Olanzapine

1999 • 515 citations

Negro, Black, Black African, African Caribbean, African American or what? Labelling African origin populations in the health arena in the 21st century

2005 • 280 citations

Clinical Pharmacokinetics of Atypical Antipsychotics

2007 • 244 citations

Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

1996 • 200 citations

Stormy Weather: Race, Gene Expression, and the Science of Health Disparities

2005 • 198 citations

Role of the Smoking-Induced Cytochrome P450 (CYP)1A2 and Polymorphic CYP2D6 in Steady-State Concentration of Olanzapine

2003 • 173 citations

Therapeutic Drug Monitoring of Olanzapine: The Combined Effect of Age, Gender, Smoking, and Comedication

2003 • 160 citations

Olanzapine Plasma Concentrations and Clinical Response: Acute Phase Results of the North American Olanzapine Trial

2001 • 138 citations

Olanzapine Plasma Concentrations and Clinical Response in Acutely Ill Schizophrenic Patients

1997 • 114 citations

Olanzapine Serum Concentrations in Psychiatric Patients Given Standard Doses: The Influence of Comedication

1999 • 109 citations

Inhibition of Caffeine Metabolism by Estrogen Replacement Therapy in Postmenopausal Women

1999 • 108 citations

Six Novel NonsynonymousCYP1A2Gene Polymorphisms: Catalytic Activities of the Naturally Occurring Variant Enzymes

2003 • 84 citations

Clinical outcome and olanzapine plasma levels in acute schizophrenia

2004 • 78 citations

Differential olanzapine plasma concentrations by sex in a fixed-dose study

1999 • 75 citations

Olanzapine Pharmacokinetics in Pediatric and Adolescent Inpatients With Childhood-Onset Schizophrenia

2000 • 73 citations

Paroxetine: population pharmacokinetic analysis in late‐life depression using sparse concentration sampling

2006 • 61 citations

Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer's Disease Trial

2003 • 57 citations

Investigation of Target Plasma Concentration-Effect Relationships for Olanzapine in Schizophrenia

2003 • 52 citations

Smoking impact on CYP1A2 activity in a group of patients with schizophrenia

2003 • 52 citations

Differential Prescription of Maintenance Antipsychotics to African American and White Patients With New-Onset Bipolar Disorder

2002 • 49 citations

Plasma concentrations of high‐dose olanzapine in a double‐blind crossover study

2006 • 45 citations

Gender differences in the pharmacokinetics and pharmacodynamics of antidepressants.

2003 • 33 citations

Population Pharmacokinetics in Geriatric Psychiatry

2006 • 27 citations

The Pharmacokinetic Imperative in Late-Life Depression

2005 • 25 citations

Gender and Antidepressants

2004 • 5 citations